[Skip to Content]
[Skip to Content Landing]
November 11, 1998

Evidence Influencing British Health Authorities' Decisions in Purchasing Complementary Medicine

Author Affiliations

Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998

JAMA. 1998;280(18):1564-1565. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-18-jbk1111

To the Editor.— The Royal London Homoeopathic Hospital NHS Trust (RLHH), to our knowledge the only independent, public-sector hospital dedicated to complementary medicine (CM) in Europe, is committed to the evidence-based practice of CM.1 The RLHH operates within the National Health Service in a system in which health authorities, led by a director of public health (DPH) and, increasingly, by primary care groups responsible for smaller populations, make health care purchasing decisions and negotiate service contracts with secondary health care institutions.